DrugRepur AI: An Explainable Knowledge Graph Embedding Platform for Drug Repurposing with Multi-Level Biological Validation
DOI:
https://doi.org/10.56511/JIPBS.2026.13108Abstract
Background: Most computational drug repurposing systems generate predictions without providing mechanistic justification, biological context, or clinical evidence. This disconnect between prediction and understanding limits practical adoption by pharmaceutical researchers. Objective: To design and validate an integrated platform combining knowledge graph embedding-based prediction with multi-level biological validation for drug repurposing hypothesis generation. Methods: A RotatE knowledge graph embedding model was trained on a DrugBank-derived knowledge graph containing 16,698 entities and 2.94 million relational triples using PyKEEN. The prediction engine was wrapped in a validation architecture comprising dual-tiered explainability (path-based and embedding-based reasoning), disease pathway analysis, drug target identification with druggability scoring, biomarker discovery via transcriptomic reversal analysis, chemical similarity search, ClinicalTrials.gov integration, literature mining, pharmacovigilance-based safety profiling, and novelty assessment. Results: Internal validation against RepoDB yielded an MRR of 0.422, Hits@10 of 65.4%, and AUC-ROC of 0.847. External validation against the independent PREDICT dataset produced Hits@10 of 40%, confirming cross-dataset generalization. Case studies on Metformin and Hydroxychloroquine demonstrated the system across known associations, novel embedding-based predictions, and path-supported hypotheses with convergent biological evidence from pathway, transcriptomic, and chemical similarity analyses. Conclusion: Knowledge graph embeddings, when integrated within structured biological validation, can produce drug repurposing hypotheses that are scientifically defensible and clinically contextualized. The multi-level evidence architecture transforms numerical predictions into testable scientific hypotheses suitable for guiding early-stage experimental investigation.
Keywords:
Drug repurposing, knowledge graph embeddings, RotatE, explainable AI, biological validation, pharmacovigilance, pathway analysisDownloads
References
DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20 - 33.
Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32(1):40 - 51.
Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41 - 58.
Himmelstein DS, Lizee A, Hessler C, Brueggeman L, Chen SL, Hadley D, et al. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife. 2017;6:e26726.
Zhang Y, Li X, Guo Y, Shi Y, Liu J, Wang Z. Machine learning and deep learning approaches for drug repurposing. Curr Med Chem. 2021;28(14):2700 - 18.
Wang Q, Mao Z, Wang B, Guo L. Knowledge graph embedding: a survey of approaches and applications. IEEE Trans Knowl Data Eng. 2017;29(12):2724 - 43.
Sun Z, Deng ZH, Nie JY, Tang J. RotatE: Knowledge graph embedding by relational rotation in complex space. In: Proceedings of the International Conference on Learning Representations (ICLR); 2019.
Zeng X, Song X, Ma T, Pan X, Zhou Y, Hou Y, et al. Repurpose open data to discover therapeutics for COVID - 19 using deep learning. J Proteome Res. 2020;19(11):4624 - 36.
Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database. Nucleic Acids Res. 2018;46(D1):D1074 - D1082.
Brown AS, Patel CJ. A standard database for drug repositioning. Sci Data. 2017;4(1):170029.
Gottlieb A, Stein GY, Ruppin E, Sharan R. PREDICT: a method for inferring novel drug indications. Mol Syst Biol. 2011;7(1):496.
Ali M, Berrendorf M, Hoyt CT, Vermue L, Galkin M, Sharifzadeh S, et al. PyKEEN 1.0: a Python library for training and evaluating knowledge graph embeddings. J Mach Learn Res. 2021;22(82):1 - 6.
Jimenez - Luna J, Grisoni F, Schneider G. Drug discovery with explainable artificial intelligence. Nat Mach Intell. 2020;2(10):573 - 84.
Mohamed SK, Novacek V, Nounu A. Discovering protein drug targets using knowledge graph embeddings. Bioinformatics. 2020;36(2):603 - 10.
Sakaeda T, Tamon A, Kadoyama K, Okuno Y. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796 - 803.
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, et al. The Connectivity Map: using gene - expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929 - 35.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Momin Mohammad Fuzail, Barrawaz Aateka Yahya, Shaikh Shoaib Iftekhar, Sarfaraz Khan

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at